Second Ebola vaccine receives approval by European Commission

The medical and pharmaceutical company Johnson & Johnson has received approval for their Ebola vaccine by the European Commission.

Both components of the two-dose vaccine for the prevention of the virus have been approved and the company hopes that this will lead to "accelerated registration" in African countries. J&J is the second company to receive approval for an Ebola vaccine after Merck.

co-founder of Pendect. Trying to protect free speech and democracies by creating a global news platform that is built through expert contribution. In love with vinyl, psytrance and penguins.
Card reviewed by: @ericof